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Approximately half of the new drug applicants that reach formulation have poor water solubility. Oral delivery 
has been the main route of drug administration for the chronic treatment of numerous diseases. In different cas-
es, in oral conveyance, 50 % of the medication compound is hampered because of the high lipid soluble or fat 
soluble of the medication itself. Around 40 % of new drug applicants show low solubility in water, which 
prompts poor oral bioavailability, high Intra and Intersubject changeability, and deficiency of dose proportion-
ality 
Aim of review. The main aim of this review article is to gather the information related to design and evaluation 
of SMEDDS. These information can be utilized to enhance the bioavailability of the poorly aqueous soluble drug 
for various types of orally administered drugs. In this review article, various literature are reviewed and sum-
merised in single paper to serve as reference guide to various research scholars and researchers working on 
self-micro-emulsifying drug delivery systems. 
Materials and Methods. To prepare this manuscript various keywords were searched in different search engine 
such as Google, Yahoo and Bing etc. This review article reviews the recent work done in the field of SMEDDS. It 
comprises review of literatures available in public domain and formulation of SMEDDS and its characterization 
is summarized in this article.  
Result. The various strategies to developed poor aqueous soluble drug for improvement of bioavailability for 
example, salt development and molecular size reduction of the compound might be one technique to enhance the 
dissolution rate of the drug. In any case, these methods have their limitations. SMEDDS is one of the novel ap-
plications for the delivery of low water soluble and low bioavailability of drug. SMEDDS is a method to improve 
the aqueous solubility of the medication; SMEDDS are described as isotropic blenders of oils, surfactants, and 
co-surfactant. Upon slightly stir followed by dilution with distilled water, for example, gastrointestinal liquids, 
these techniques can define clear o/w micro emulsion. SMEDDS is first choice and key technology for develop-
ing the lipophilic drug and other different factors that chance to affect the oral bioavailability.  
Conclusions. This review paper attempts to describe the preparation of SMEDDS and furthermore discusses the 
development of pseudo ternary phase diagram for SMEDDS. It describes the mechanism and method of prepara-
tion involved in SMEDDS. The capability of oral absorption of drug compound from the SMEDDS relies upon nu-
merous formulation−related parameters, for example, surfactant concentration, oil/surfactant ratio, and hydro-
phobicity of emulsion, globule size and charge, in vitro, in vivo all of which basically characterized the ability of 
self-emulsification. SMEDDS are administered as unit dosage form and it also protect the degradation of drug. 
Keywords: SMEDDS (self micro emulsifying drug delivery system), GI fluids (gastrointestinal fluids), o/w (oil in 
water), optimization, Isotropic mixture, X-ray powder diffraction (XPRD), zeta potential, surfactant, co-
surfactant 
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1. Introduction 
The various technique is utilized to enhance 
oral bioavailability of the poorly water-soluble drug, 
the oral route has been the ideal route of drug admin-
istration for the endless treatment of diseases as it 
offers more patient compliance [1]. 40 % of new drug 
applicants show low solvency in water, which is a test 
being developed of the ideal oral solid dosage form as 
far as formulation development and bioavailability of 
new pharmaceutical preparation [1, 2]. Various strate-
gies are used for improving the bioavailability of those 
medications like the salt arrangement, pH change, β-
cyclodextrin complex, microemulsion, and so forth 
[3]. SMEDDS is the best and most preferable method 
for the enhancement of oral bioavailability. SMEDDS 
are class of emulsion that has gotten specific consider-
ation as a method for upgrading oral bioavailability of 
poor soluble drugs [4].  
SMEDDS or self-emulsifying oil formulations 
(SEOF) are characterized as isotropic blends of natural and 
synthetic oils, delete these words, surfactants, or then 
again, at least one hydrophilic solvents and co-
solvents/surfactants [2, 3]. SEDDS ordinarily produce 
emulsions with a globule size somewhere in the range of 
100 and 300 nm while SMEDDS can have droplet size 
somewhere near 50 nm [3, 5].  
 
2. Mechanism of self-emulsification  
The mechanism by which self-emulsification hap-
pens is not yet surely known. All things considered, it 
has been proposed that self-emulsification happens when 
the entropy change is the energy required to build the 
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surface region of the dispersion to the higher than the 
preferring of dispersion.  
The free energy of a simple emulsion preparation 
is a direct working of the energy required to make the 
most recent surface between the water and oil phases. 
The two periods of the emulsion will intend to 
separate with time to decrease the interfacial region and 
in this manner the free energy of the system is done. 
Fig. 1 explain the mechanism of action of oral admin-
istration of SMEDDS on oral administration of drug [5]. 
 
 
Fig.1. Mechanism of action of self-micro-emulsifying drug delivery system on oral administration of drug 
 
2.1. Advantages of SMEDDS 
Although SMEDDS formulation has several ad-
vantages:  
1. Minimizing disturbance with the contact of GIT 
and gut wall. 
2. Deliver peptides that are inclined to enzymatic 
hydrolysis in GIT. 
3. It gives a sustained release of medicaments 
when a polymer is consolidated. 
4. Safe and simple synthesis of SMEDDS. 
5. More predictable fleeting profiles of medication 
assimilation. 
6. Particular medication focusing on a particular 
replace ingestion with absorption window in the GI tract. 
7. Drug security from the threatening condition in 
the gut. 
8. The tale approach will upgrade water dissolva-
bility and ultimate improve the availability of the lipo-
philic medication. 
9. It demonstrates large inter and Intrasubject var-
iable in absorption prompting variance over plasma pro-
file solid or liquid dosage forms [6]. 
 
2.2. Limitations of SMEDDS 
There are certain limitations associated with this 
system: 
(1) Drug precipitation on dilution: diluted 
SMEDDS endure precipitation of drug into the gastroin-
testinal fluid. A regular need for the lipophilic formula-
tions will be that they might have the capacity to have the 
drug in the solubilized manifestation in the gastrointesti-
nal tract (GIT). 
Precipitation of the drug from the system nullifies 
the benefits accessible by the lipid-based formulation 
system [7]. 
(2) The precipitation property of the formulation 
on dilution impact will be higher because of the impact 
of the hydrophilic solvents. It also requires the addition 
of polymers to decrease drug precipitation in vivo [7].  
(3) Encapsulation in soft gelatine capsules: a 
large portion of the marketed SMEDDS preparations are 
accessible a soft gelatine capsule. Be that as it may, the 
gelatine capsule is related to few disadvantages. Assem-
bling cost, transmissible spongiform encephalopathy 
(TSE), and purchaser inclination/religion are a couple of 
issues related to animal gelatine. Volatile co-solvents 
self-micro emulsifying drug delivery system are as well 
known to transmigrate into the shells of hard or soft 
gelatine capsule, ensure about the precipitation of the 
lipophilic medications. These issues drive the market 
necessity to locate a substitute for a soft gelatine capsule. 
The ongoing corresponding material of choice are those 
formulated from HPMC. The HPMC capsule shell has 
been investigated as a complementary methodology for 
encapsulating super saturable SMEDDS formulation [7]. 
(4) Storage and handling: liquid SMEDDS cre-
ate issues in storage, stability, and handling. As such, S-
SMEDDS has all the earmarks of being an all sensible 
answer to address these issues [7]. 
(5) Limited targeting to lymphatic: focusing on 
lymphatics presents two essential advantages over con-
ventional assimilation through the portal blood. To start 
with, transport through the intestinal lymph avoids pre-
systemic hepatic metabolism and thereby improves the  
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concentration of orally administered medications reach-
ing the systemic circulation. Second, a site-specific drug 
administered to lymphatic organs could be accomplished. 
Normally high triglyceride solubility and high log P is 
required for lymphatic transport. However, the amount of 
drug transported into lymphatics is variable from drug to 
drug. Thus, lipophilicity and triglyceride solvency of the 
drug in relationship with the lymphatic vehicle should be 
understood and a more satisfactory prescient model is 
needed. [7]. 
(6) Lack of good in vitro models: another diffi-
culty in the improvement of self-micro emulsifying drug 
delivery systems and other lipid-based arrangements is 
the absence of good predictive in-vitro models for the 
assessment of the formulation. Traditional dissolution 
strategies do not work, as these preparations theoretically 
are reliant on the metabolism of lipid in the gut, preced-
ing to release of the drug. However, to imitate this, an in-
vitro model simulating the metabolism of the duodenum 
has been established. This in-vitro model needs further 
modification and validation before its strength can be 
evaluated. Further, improvement can be based on in-vitro 
in-vivo relationships, and hence various model lipid-
based preparations should be established and assessed in-
vivo in an appropriate animal model [7]. 
(7) Oxidation and polymorphism of the lipids 
used in formulating SEDDS/SMEDDS: lipid excipients 
containing unsaturated fats and its subordinates are to 
lipid oxidation. This requires consideration of lipid solu-
ble antioxidant in preparation of capsules. Polymorphism 
related with thermo-softening up lipid excipients requires 
explicit procedure control in their application, to dimin-
ish polymorphic changes of the excipient matrix [7]. 
 
2.3. Composition of SMEDS 
Various literature survey which are used to oil/ 
surfactant and co-surfactant physical mixture of the for-
mulation of SMEDDS in different ratio. Most of the 
literatures used to surfactant and co-surfactant mixture 
(Smix) with oil in different ratio are used to prepare the 
SMEDDS preparation. Various components are used in 
SMEDDS formulation. As show in the table below.   
 
Table 1 
Classification of excipients used in formulation of SMEDDS on the basis of various literatures survey 
No. Oil Surfactant Co-Surfactant Reference 
1. Capmul MCM C8 Cremophor EL Transcutol HP [8] 
2. castor oil Tween-20 Propylene glycol [9] 
3. Triacetin Triton-X100 Carbitol [10] 
4. Castor oil Capmul MCM, Kolliphor EL Kolliphor RH 40 [11] 
5. Capryol 90 gelucire 44/14 Tween 80 [12] 
6. Isopropyl myristate (IPM) Tween 80 propylene glycol [2] 
 
 





4. Consistency builder 
5. Polymer 
6. Other components 
1. Oils: the oil refers to the most significant ex-
cipient in the SMEDDS formulation. Without a doubt, it 
will solubilize the important measure of the poor soluble 
dug [6]. Both medium-chain triglyceride (MCT) and 
long-chain triglyceride (LCT) oils with various degrees 
of immersion have been utilized in the design of 
SMEDDS [13]. For example, corn oil, olive oil, soybean 
oil, hydrolyzed corn oil, castor oil, sesame oil, soyabean 
oil isopropyl myristate [13, 14]. 
2. Surfactant: surfactant molecules may be clas-
sified based on the nature of the hydrophilic group within 
the molecule [13]. The surfactants are defined as four 
main categories as follows [6]. 
a. Anionic surfactants: the anionic surfactant is a 
water-loving group that conveys a negative charge [13]. 
For example, carboxyl (RCOO-), sulphonate (RSO3-) or 
sulfate (ROSO3-). Potassium laurate, Sodium lauryl Sul-
phate (SLS) [6]. 
b. Cationic surfactants: the cationic surfactant is 
a hydrophilic component that passes on a positive charge. 
For example, quaternary ammonium halide [6] 
c. Zwitterionic surfactants (also called Ampho-
lytic surfactants): the ampholytic surfactant contains 
both a positive charge (+ve) and a negative charge (-ve.) 
Such as sulfobetaine [6, 13].  
d. Non-ionic surfactants: the non-ionic surfac-
tant is a polar group they do not pass any type of 
charge yet get its water solubility from highly hydro-
philic groups, such as polyoxyethylene or hydroxyl, 
for example, tween. The non-ionic surfactant 
SMEDDS formulation is used with high HLB value 
and there surfactant capability ranges are 30–60 % 
w/w of the preparation to appearance a stable self- 
micro emulsifying drug delivery system (SMEDDS). 
Surfactants contain a high HLB, and polar groups help 
the rapid formation of oil/water droplets just as quick-
ly disperse of the preparation in the fluid media. Non-
ionic surfactants are amphiphilic on character and they 
can solubilize a respectably high amount of hydropho-
bic drugs [6, 13].  
3. Co-solvents: co-surfactant is an organic sol-
vent, for example, ethanol, propylene glycol, and poly-
ethylene glycol (PEG) are suitable for oral conveyance 
and they accelerate the dissolution of huge amounts of 
either the water-loving or the lipid-soluble drug surfac-
tants [13]. These solvents will even work as co-
surfactants in microemulsion preparation. Then again, 
liquor and other co-surfactants have the burden that of 
dissipating into the shells of the delicately wrapped gela-
tine or hard gelatine case unmistakable [15, 16]. 
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4. Consistency builder: additional material can 
be added to adjust the consistency of the emulsion; for 
instance, stearic corrosive, cetyl liquor, tragacanth, and 
beeswax, etc. [6]. 
5. Polymers: inert polymer matrix denoting from 
5-40 % of ingredient comparative to the weight, which is 
not ionizable at physiological pH, and being able of de-
veloping matrix. Examples are HPMC, ethyl cellulose, 
etc [6]. 
6. Other components: various constituents may 
be flavours, antioxidant agent and pH adjusters. To be 
sure, properties of lipid products, mostly those with un-
saturated lipids express peroxide materialization with 
oxidation. Free radicals, for example, Peroxyl (ROO), 
Alkoxide (RO), and Hydroxyl (OH) can harm the drug 
and produce toxicity. Lipid peroxides may too be de-
signed because of auto-oxidation, which increases with 
the unsaturation level of the lipid molecule. Hydrolysis of 
the lipid high speed up because of the pH of the solution or 
from required processing energy, such as ultrasonic radia-
tion. Lipophilic antioxidants (for example α-tocopherol, 
propyl gallate, BHT) may in this manner be required to 
maintain the oily substance of the SMEDDS [6]. 
Formulation design: formulation of SMEDDS 
involves the following steps. 
(1) Selection of active pharmaceutical ingredient 
(API) for self-micro-emulsifying drug delivery system 
(SMEDDS).  
(2) Screening of surfactant for emulsifying ability. 
(3) Choice of excipients for self-micro-
emulsifying drug delivery system (SMEDDS).  
(4) The solubility of a drug in oils, surfactant, and 
co-surfactant. 
(5) Construction of pseudo ternary phase diagram. 
(6) Preparation of self-micro-emulsifying drug de-
livery system (SMEDDS).  
(7) Factor influencing self-micro-emulsifying 
drug delivery system.  
(8) Characterization and evaluation of SMEDDS. 
(1). Selection of active pharmaceutical ingredi-
ent for SMEDDS: it is most significant to know that the 
active pharmaceutical ingredient of choice can similarly 
have a considerable effect on the different features of 
SMEDDS, for example, phase behaviour and micro-
emulsion particle size [1]. 
Different physicochemical characteristics of the 
API, for example, pKa, log P, atomic structure and 
weight, presence of the ionizable group, and the amount 
have a significant effect on the functioning of SMEDDS 
[18]. Drugs that have low therapeutic dose are standard 
drug applicants for SMEDDS [19]. One of the major 
difficulties in developing oral preparation is keeping up 
active pharmaceutical ingredient soluble inside the G.I.T. 
furthermore, specifically, capitalize on drug dissolvabil-
ity inside the major absorptive site of the gut drugs which 
are administered at extremely high dose are not appropri-
ate for SMEDDS, except if they have great solubilization 
in at any rate one of the excipients of SMEDDS, ideally 
lipophilic phase. 
The drug must be stable physically and chemical-
ly in the preparation and the drug discharge rate design 
must remain stable during the self-life of the SMEDDS 
[18]. 
(2). Screening of surfactant for emulsifying 
ability: the different surfactants are screened for their 
emulsification capacity. Surfactants can be added to the 
particular oil in 1:1 ratio. The admixture is homogenized. 
A fixed quantity of isotropic admixture is diluted with 
double purified water to yield a clear emulsion [19, 20]. 
The resulting emulsions can be inspected outwardly for 
their relative polluting influence and their transmittance 
can be evaluated in UV-visible spectrophotometer with 
the help of double purified water as the blank [21–23]. 
(3). Selection of excipients: the excipients should 
be preferred from the record of generally regarded as safe 
"GRAS" excipients printed by USFDA [19, 24]. Good 
consideration of the physical appearance of excipients 
and their performance in preparation is the essential 
desire for effective preparation development [25]. In 
orderliness to prepare an effective SMEDDS for highest 
therapeutic outcomes, outstanding thought must be given 
to the following components; 
• physicochemical characteristics of the API as 
well as excipients; 
• development for drug excipients collaboration; 
• physiological aspects that stimulate or restrain 
the bioavailability; 
• biopharmaceutical features such as solubilization 
capacity, physical state regulatory status, miscibility, of 
the excipients at 25 °C; 
• regulatory features of excipients; 
• the temperature at which self-emulsification 
occurs. 
When the preparation of SMEDDS, APIs must be 
consolidated into a suitable admixture of excipients; in 
this way, preparation enhancement usually begins with 
excipients assurance that was proposed to spare time and 
inexpensive. During the first choice of study, some ex-
cipients are recognized as potentially suitable for addi-
tional exploration attributable to their safety, sedate sol-
vency, and their stability [19, 26].  
(4). The solubility of a drug in oils, surfactant, 
and co-surfactant: the dissolvability of medication in 
oils, surfactant, and co-surfactant: the aggregate of the 
oils surfactants, and co-surfactants were screened for 
their attributes to dissolve a tremendous amount of pure 
drug [27]. An additional quantity of the drug is taken in 
clear screw cap glass vials that confine oil/surfactant/co-
surfactant followed by blending on cyclomixer (vortex 
mixture). The admixture is shaken and centrifuged [28]. 
An aliquant part from the supernatant is withdrawn and 
further analyzed by UV–Visible Spectrophotometer at 
required nm [28, 29].  
(5). Construction of pseudo ternary phase dia-
gram: different proportions of oil, surfactant, and co-
surfactant are agitated to formulate various techniques 
[30, 31]. Fixed quantity of each system is added in a 
beaker containing 0.1 N HCl at 37°C and the substances 
are mixed using the magnetic stirrer [32, 33].  
The clearness of the designed dispersion was vis-
ually examined with the help of following grading tech-
niques; 
A. Denoting the clear micro emulsion formation 
with bluish ting. 
B. Denoting a translucent micro emulsion for-
mation had a bluish appearance.  
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C. Denoting a little less clear emulsion prepara-
tion. 
D. Indicating a clear white emulsion development. 
E. Signifying the details which had either poor 
emulsification with huge oil droplets superficially or the 
emulsion was not developed. 
A phase diagram is developed to distinguish the 
results. Type A and B systems are most preferred be-
cause of the lower particle size. The following pyramid 
like structure over there shows the construction of pseu-
do ternary phase diagram. The following Fig. 2 demon-




Fig. 2. Construction of pseudo ternary phase diagram 
 
(6). Preparation of SMEDDS: the formulation 
contains the addition of the drug to the admixture of oil, 
surfactant, and co-surfactant and then it must be exposed 
to vertexing [36]. At that time, the drug is solubilized in 
any of the excipients and the remaining excipients are 
added to the drug solution [37, 38]. At that point, the 
solution must be appropriately admixture and tested for 
the indication of impurity [39, 40]. After equilibration at 
atmospheric temperature for 48 hours, the solution must 
be heated for the development of a fine solution, when-
ever required [41, 42]. Contingent on the final volume, 
the preparation must be put away in capsules of appro-
priate size. The general technique of preparation a self-
micro-emulsifying drug delivery system and their result-
ing form to micro emulsion /nano-emulsion is shown in 
Fig. 3 [36, 43].  
(7). Factor affecting SMEDDS: 
(a) API dose: generally drugs having a low thera-
peutic dose is preferred for the formulation of SMEDDS. 
However, such drugs are highly soluble in any constitu-
ents of SMEDDS specifically in the lipid phase. The 
drug which is not well dissolvable both in oil and water 
and has low Log P-value (around 2) is not an appropriate 
contender for SMEDDS [6].  
(b) Drug solubility in the oil phase: the solubil-
ity of drugs in the oil phase influenced the capacity of 
the SMEDDS system in keeping the medication in the 
solution state. Right when the medication is solvent 
with the assistance of surfactant and co-surfactant the 
weakening of SMEDDS can bring about diminishing 
the dissolvable ability of surfactant, thereby coming 
about precipitation [6].  
(c) The polarity of lipid phase: it is one of the 
variables that oversee the release of the micro emulsion. 
HLB, chain length and degree of unsaturation of the 
unsaturated fat, molecular weight of the water-loving 
segment and concentration of the emulsifier control po-
larity of the globules. Indeed, the polarity reproduces the 
affinity of the drug for oil as well as water and the kind 
of involved energies. The maximum polarity will im-
prove the high degree of release of the drug into the 
aqueous phase. The maximum release was achieved with 
the preparation that had an oily state with maximum 
polarity.  
The stability of dissolvability estimation can be 
completed to anticipate potential cases of precipitation in 
the gut. However, crystallization could be delayed insol-
ubilizing and colloidal become stable out the condition of 
the gut. Studies express that such formulation can take up 
to 5 days to arrive at equilibrium and that medication can 
remain supersaturated state up to 24 hours after the pri-
mary emulsification occasion [6].  
 
Fig.3. The general technique of preparation a self-micro-emulsifying drug delivery system and their resulting form to 
micro emulsion /nano-emulsion. 
 
(8). Characterization and evaluation of 
SMEDDS:  
The efficiency of self-micro-emulsification could 
be estimated by determining the evaluation parameter [36]. 
1. Visual evaluation: the evaluation of self-
emulsification is achieved by visual assessment. After 
dilution of SMEDDS with water, the impervious and 
milky white occurrence shows the development of macro 
emulsion though the fine, isotropic, clear solution shows 
the development of micro emulsion [36]. The preparation 
can be considered as constant when drug precipitation is 
not distinct [44]. Precipitation is normal if the preparation 
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contains water soluble co-solvents and can be prevented 
by increasing the concentration of surfactant [36, 45].  
2. Droplet size and particle size measurement: 
the globule size of the microemulsion is the measurement 
by PCS (photon correlation spectroscopy) or SEM (Scan-
ning Electron Microscopy) which can evaluate sizes be-
tween 10-5000 nm [46, 47]. The nanometric size range of 
the molecule is held significantly after 100 or 1000 times 
diluted with distilled water, which identifies the system's 
compatibility with excess water [6]. Globule size is signif-
icant factors in SMEDDS because it impacts the rate and 
extent of drug discharge it also influences the stability of 
the micro-emulsion the globule size of the micro-emulsion 
is estimation by PCS (which estimate the varieties in light 
scattering due to Brownian movement of the particles) 
[48-50] which can measure size range between in the 
range of 10 and 5000 nm. Light scattering is observed at 
room temperature at a 900 angle after outer standardiza-
tion with spherical polystyrene droplets [51–53].  
3. Refractive index and percent transmission: 
refractive index and percentage transmittance show the 
transparency of preparations [54, 55]. The refractive 
index (RI) of the SMEDDS is a determined with refrac-
tometer and differentiates with water one [56]. The per-
cent transmittance of the approach is determined at a 
specific wavelength (WL) using an ultraviolet-visible 
spectrophotometer maintaining purified water as blank if 
the refractive index (RI) of the system must be like that 
of water [57]. Preparation demonstrating transmittance 
>99 % is transmittance in nature [58, 59].  
4. Zeta potential measurement: zeta potential is 
normally determined by the zeta potential analyzer or 
zeta meter system [60]. The estimation of the zeta poten-
tial analyzer indicates the constancy of emulsion after 
appropriate dilution [61]. Higher zeta potential shows a 
better constancy of the formulation. Generally, the value 
of zeta meter system is negative as a result of the free 
unsaturated fats yet when cationic lipid [62, 63]. For 
example, oleylamine is utilized, the charge contains the 
property of interfacing successfully with the mucosal 
surface of the GIT and these interchanges are electrostat-
ic nature because of which solid adhesion can be estimat-
ed with improved absorption [36, 64].  
5. Differential scanning colorimetry. This is 
generally used for the evaluation of micro-emulsions that 
are constructed by dilution of self-micro-emulsifying 
drug delivery system (SMEDDS) in the designation of 
peaks equivalent to water [36, 65]. The peaks give data 
about the condition of water like a bound state or free 
state [66]. Purified water is utilized as a reference which 
shows high, sharp peaks around at -170°C that demon-
strates the point of freezing [67]. DSC experimentations 
microemulsions of water, surfactant and co-surfactant 
system and recognized identified peaks comparing to the 
water at a lower temperature than the purified water 
(roughly at -450°C at 15 % w/w) demonstrating the ap-
pearance of water in the bound state in microemulsions 
ideally bound to surfactants [68, 69]. A more high con-
centration of water than this prompts the move to a high-
er temperature [70]. From the examination of the thermal 
behaviour of water, they determined that the high con-
centration of water (>35 %W/W) manufactured O/W 
micro emulsions [36, 71, 72].  
6. NMR techniques. The NMR technique after di-
lution of self-micro-emulsification systems to the prepared 
micro emulsion structure was determined. (FT-PGSE) 
Fourier transforms pulsed gradient spin-echo technique is 
used to examine the dispersive properties of micro-
emulsion constituents. PGSE-NMR strategy is utilized to 
analyzed the progressions between micro emulsion phase 
and bi-consistent phase upon dilution with the help of 
129xe NMR (nuclear magnetic resonance), the globule 
size of the micro emulsion can be measured with the help 
of observing the shift of signal to higher with particularly 
improve in the size of globules [36]. The self-dispersion 
NMR studies are utilized to evaluate the type of micro-
emulsion that is formulated after dilution of SMEDDS and 
to evaluate the changes like W/O (water in oil) to be con-
tinuous and bi-continuous to O/W (oil in water) type upon 
increasing dilution. In this method, the self-diffusive coef-
ficients of various constituents of micro-emulsion are 
differentiated with that of pure constituents. if the disper-
sion of one of the constituents is lower than that of pure 
constituents, this shows the existence of globules, that is, 
O/W (oil in water) or W/O (water in oil), and generally, 
surfactant and co-surfactants as well have slow dispersion 
due to the development of layer around the globules by 
these constituents.  
If the oil and water phase has high dispersion co-
efficients and is of a similar magnitude as pure constitu-
ents, it shows the presence of bi-continuous micro-
emulsion [36]. 
7. Small angle x-ray and neutron scattering meth-
ods: this kind of technique is valuable for the estimation of 
structures that are formed by dilution of SMEDDS [72]. 
Assessment of fluid crystalline structures developed by the 
dilution of SMEDDS is significant as these control stability 
the preparation, self-emulsification, and amount of drug 
discharge X-Ray scattering examine on preparations contain-
ing various ratios of water. At 10 % w/w (lower) water conc. 
lamellar structure was analyzed and at 20 % w/w water con-
centration, lamellar structures were inspected [73]. Further 
increase in water concentration to 40 % w/w uncovered 
hexagonal or lamellar structures. The temperature increasing 
to 37°C from 25°C did not cause important changes in fluid 
crystalline structures that are developed [74]. Small-angle 
neutron scattering techniques are helpful to examined transi-
tions in micro-emulsion structures upon dilution and to ob-
served the size and shape of the globules [36, 75]  
8. In vitro release. USP dissolution testing me-
chanical assembly type-II (paddle type) ought to be uti-
lized for evaluation of the in-vitro drug discharge [76]. 
The dissolution test utilize a reasonable dissolution me-
dium at 37°C ± 5°C. The rotation speed of the paddle 
should be maintained at 75 rpm for 1 hrs. The study was 
performed as per the USP procedure. In dissolution ves-
sel weight equivalent weight of preparation is added [77, 
78]. At regular intervals, the appropriate volume of sam-
ples is withdrawn from the middle of vessels [79].  
The sink condition is maintained by adding a fresh 
volume of dissolution media after withdrawing the sample 
[80, 81]. After withdrawing the sample is filtered and ob-
served in UV-spectrophotometer against blank in its respec-
tive range of λ max. The percent of drug dissolved from 
preparation is determined. The above strategies were re-
hashed three times for every preparations [28, 82, 83]. 
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9. Stability 
(a) Temperature stability: by visual perception of 
the SMEDDS system at the different time span the shelf life 
as a function of time and the storage temperature is resolved 
[5]. By utilizing distilled water, preparations are diluted and 
are kept at a different scope of temperature (room tempera-
ture, 2-8°C or cooler) to check the temperature soundness of 
tests, and if any signs of phase separation, flocculation or 
precipitation is generally watched [84, 85].  
(b) Centrifugation: to assess metastable system, 
the improved SMEDDS system are diluted with dis-
tilled water [5]. At this point, micro-emulsion are cen-
trifuged at 1000 rpm for 15 minutes at 0°C and inspect-
ed for any adjustment in the homogeneity of small scale 
emulsions [86, 87, 88].  
10. In-vivo studies: there are the number of mod-
els that are utilized for conducting in vivo studies. 
Every in vivo studies involving animal, to be 
granted permission by animal ethics committees and the 
researches are mandated to follow those guidelines [89, 
90]. The study was controlled in three groups involving 
six animals in each group were divided.  
Table 2 explain the various types of animal model 
and route of drug administration in SMEDDS [91, 92]. 
 
Table 2 
Different animal models utilized for in-vivo absorption studies in SMEDDS 
Animal model Drug Route of drug administration References 
New Zealand male rabbits. Nimodipine Oral [93] 
Male albino Rat. Acyclovir Oral [94] 
Beagle dogs (Male). Atorvastatin Oral [95] 
Female Wistar Rats. Exemestane Oral [96] 
 
Bioavailability study in rat 
Male rodents are arbitrarily separated into two 
groups, in particular free standard drug solution and 
SMEDDS formulation containing drug [97]. Prior to the 
analysis, the rodents are housed for 72 h to adapt to the 
laboratory conditions and free access to water can be 
permitted. The two groups were given a similar dose 
[98]. Blood samples are collected at various time inter-
val. The samples are centrifuged at 10,000 rpm for 5-10 
minute. The concentration of drug can be determined 
using HPLC [99–101].  
 
3. Conclusion 
Self-micro emulsifying drug delivery system for-
mulation is formulated for the enhancement of oral bioa-
vailability of poor soluble and low bioavailability of 
drug. It is most appropriate method to increase the drug 
solubility and bioavailability in oral administration of 
drug. The oil, surfactant and co-surfactant mixture is 
gently agitated followed by dilution of aqueous media. It 
forms clear oil/water micro emulsion. In this review, 
various components for preparation of SMEDDS is 
studied to help the researchers to choose the most 
appropriate component for their research. There are 
various types of evaluation parameter which are used 
to assess SMEDDS like particle size and there crystal-
line structure, charge of the particle in the formulation. 
This article also discusses various in vivo models to 
study characterize SMEDDS. This review article will 
serve as a base for the researchers working on 
SMEDDS, techniques used for enhancement of bioa-
vailability, aqueous solubility of drugs.  
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